The FDA has granted Fast Track designation to dubodencel (DOC1021) for unresectable or metastatic cutaneous melanoma. The ...
Researchers at MD Anderson have identified RNase H2 as a key survival mechanism in triple-negative breast cancer, helping ...
A pan-cancer analysis of 2,930 patients across 11 tumor types found that ALK mutation was associated with significantly ...
FDA’s advisory committee has endorsed Truqap plus abiraterone and ADT as a treatment option with a favorable benefit-risk ...
The Zeta Navigation System has received FDA 510(k) clearance alongside the Zeta Stylet and Zeta Bolt, expanding real-time, AI ...
Sonire’s first U.S. study of ultrasound-guided, anesthesia-free HIFU ablation therapy has been launched for patients with ...
FDA has approved vepdegestrant (VEPPANU), the first PROTAC therapy, for adults with ESR1-mutated ER+/HER2- advanced or ...
A new American Academy of Dermatology survey finds that social media misinformation has driven more than 16 million U.S.